| Transport Package: | Bottle, Can, Drum, Vial, Plastic Container |
|---|---|
| Specification: | powder |
| Trademark: | Senwayer |
| Origin: | Wuhan, China |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
1. Product Basic Information
| Product name | Aniracetam |
| CAS No. | 72432-10-1 |
| MF | C12H13NO3 |
| MW | 219.24 |
| Melting point | 121-122?C |
| Boiling point | 399.7±34.0 °C(Predicted) |
| Density | 1.236±0.06 g/cm3(Predicted) |
| Storage | Sealed in dry,Room Temperature |
Aniracetam is a potent, fast-acting nootropic that may enhance cognition and improve mood.
Discovered in the 1970s by Swiss pharmaceutical company Hoffman-LaRoche, aniracetam is available as a prescription drug in Europe but is unregulated in the US, Canada, and the UK.
Aniracetam is similar to piracetam, the first synthetic nootropic, and was initially developed as a more potent alternative.
Aniracetam is part of the racetam family of nootropics, a group of synthetic compounds similar in both chemical structure and mechanisms of action.
Like other racetams, aniracetam works primarily by modulating the production and release of neurotransmitters and other brain chemicals.
3. Product Benefits
Aniracetam's reputation as a memory enhancer is backed up by research that indicates that it can improve functional memory and even reverse memory impairment.
In a study involving healthy human subjects, aniracetam was found to improve various aspects of memory, including visual recognition, motor performance, and general intellectual functioning.
In animal studies, aniracetam was found to enhance memory by positively impacting the levels of acetylcholine, serotonin, glutamate, and dopamine in the brain.
A more recent study concluded that aniracetam did not improve healthy adult mice's cognitive abilities, suggesting that aniracetam's effects may be limited to those with cognitive impairment.
Many users consider aniracetam to be one of the best nootropics for improving focus and concentration.
Though no human studies have centered on this aspect of the compound, its well-documented effects on acetylcholine, dopamine, and other essential neurotransmitters strongly support this hypothesis.
Aniracetam also acts as an ampakine, stimulating the glutamate receptors involved in memory encoding and neuroplasticity.
One of aniracetam's most notable characteristics is its potential as an anxiolytic (anxiety reducer).
Animal studies showed that aniracetam effectively reduced anxiety and increased social interaction in rats, possibly by a combination of dopaminergic and serotonergic actions.
There are no documented studies specifically focusing on aniracetam's anxiolytic effect on humans. However, a clinical trial on its use as a treatment for dementia did indicate that subjects taking aniracetam experienced less anxiety.
Many users report decreased anxiety when taking aniracetam.
Aniracetam also proved to be an effective antidepressant in aged rats, significantly diminishing stress-induced immobility and brain dysfunction associated with aging.
Whether the antidepressant properties found in the animal study finding holds for humans has yet to been confirmed.
Aniracetam's potential antidepressant properties may be due to increased dopaminergic transmission and acetylcholine receptor stimulation.
One of the few human studies on aniracetam suggests that it may be an effective treatment for individuals with dementia.
Dementia patients treated with aniracetam demonstrated significantly better cognitive performance, improved function, and enhanced mood and emotional stability.
FAQ
Our Product purity and quality is guaranteed by lab test for each batch
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}